Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
November 23, 2021
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry
Anas Alawawdeh, Timothy Price, Christos Karapetis, et al.
Cancer
|
November 8, 2014
Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
Timothy J Price, Carol Beeke, Shahid Ullah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 17, 2014
Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years
Sunita Padman, Jaein Lee, Rajiv Kumar, et al.
Journal of Gastrointestinal Cancer
|
January 26, 2026
Bowel Function in Survivors of Rectal Cancer Managed with Watch-and-Wait Versus Surgery
Sina Vatandoust, Luigi Sposato, David Wattchow, et al.
Cancer Biology & Medicine
|
January 27, 2018
Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry
Gonzalo Tapia Rico, Timothy J Price, Christos Karapetis, et al.
Targeted Oncology
|
October 17, 2020
Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
Li Chia Chong, Jennifer E Hardingham, Amanda R Townsend, et al.
Clinical Colorectal Cancer
|
June 19, 2026
Comparing Quality of Life in Rectal Cancer Survivors Managed With Watch-and-Wait Versus Surgery
Sina Vatandoust, Luigi Sposato, David Wattchow, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 19, 2018
Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry
Gonzalo Tapia Rico, Christos Karapetis, Amanda R Townsend, et al.
Cancer Reports (Hoboken, N.J.)
|
March 4, 2021
Predicting chemotherapy-induced menopause using baseline and post-chemotherapy anti-Müllerian hormone levels: Results of a pilot study
Hilary Laura Martin, Shahid Ullah, Nazim Abbas, et al.
Expert Review of Anticancer Therapy
|
July 19, 2018
Targeted therapy for metastatic colorectal cancer
Timothy J Price, Monica Tang, Peter Gibbs, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Asia-Pacific Journal of Clinical Oncology
|
November 23, 2021
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry
Anas Alawawdeh, Timothy Price, Christos Karapetis, et al.
Cancer
|
November 8, 2014
Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
Timothy J Price, Carol Beeke, Shahid Ullah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 17, 2014
Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years
Sunita Padman, Jaein Lee, Rajiv Kumar, et al.
Journal of Gastrointestinal Cancer
|
January 26, 2026
Bowel Function in Survivors of Rectal Cancer Managed with Watch-and-Wait Versus Surgery
Sina Vatandoust, Luigi Sposato, David Wattchow, et al.
Cancer Biology & Medicine
|
January 27, 2018
Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry
Gonzalo Tapia Rico, Timothy J Price, Christos Karapetis, et al.
Targeted Oncology
|
October 17, 2020
Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
Li Chia Chong, Jennifer E Hardingham, Amanda R Townsend, et al.
Clinical Colorectal Cancer
|
June 19, 2026
Comparing Quality of Life in Rectal Cancer Survivors Managed With Watch-and-Wait Versus Surgery
Sina Vatandoust, Luigi Sposato, David Wattchow, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 19, 2018
Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry
Gonzalo Tapia Rico, Christos Karapetis, Amanda R Townsend, et al.
Cancer Reports (Hoboken, N.J.)
|
March 4, 2021
Predicting chemotherapy-induced menopause using baseline and post-chemotherapy anti-Müllerian hormone levels: Results of a pilot study
Hilary Laura Martin, Shahid Ullah, Nazim Abbas, et al.
Expert Review of Anticancer Therapy
|
July 19, 2018
Targeted therapy for metastatic colorectal cancer
Timothy J Price, Monica Tang, Peter Gibbs, et al.
Page
of 5